Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Chemoresistance of TP53 mutant AML requires the mevalonat... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Chemoresistance of TP53 mutant AML requires the mevalonate byproduct, GGPP, for regulation of ROS and induction of a mitochondria stress response
0
Authors
Sarah Scotland
•
A’ishah Bakayoko
30 more
•
Martin Carroll
Published
June 11, 2024
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to comment
Add a comment...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Preprint Server
Topics
Biochemistry
Cancer Oncology
Biology
Biochemistry
Chemistry
Cancer Oncology
Molecular Biology
Show all topics
DOI
10.1101/2024.06.07.597976
License
CC-BY-NC-ND
Other Formats
PDF
